NCT03608371View on ClinicalTrials.gov

BTRX-246040 Study in Participants With Parkinson's Disease With Motor Fluctuations

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2018

Primary Completion Date

April 16, 2019

Study Completion Date

April 23, 2019

Conditions
Parkinson DiseaseMotor Disorder
Interventions
DRUG

BTRX-246040

oral capsule

DRUG

Placebo

oral capsule matching BTRX-246040 capsule

Trial Locations (4)

27705

BlackThorn Investigator Site, Durham

33009

BlackThorn Investigator Site, Hallandale

48334

BlackThorn Investigator Site, Farmington Hills

75390

BlackThorn Investigator Site, Dallas

Sponsors
All Listed Sponsors
lead

BlackThorn Therapeutics, Inc.

INDUSTRY